E-viri
Recenzirano
-
Stacey, Simon N; Stefansson, Kari; Manolescu, Andrei; Sulem, Patrick; Rafnar, Thorunn; Gudmundsson, Julius; Gudjonsson, Sigurjon A; Masson, Gisli; Jakobsdottir, Margret; Thorlacius, Steinunn; Helgason, Agnar; Aben, Katja K; Strobbe, Luc J; Albers-Akkers, Marjo T; Swinkels, Dorine W; Henderson, Brian E; Kolonel, Laurence N; Le Marchand, Loic; Millastre, Esther; Andres, Raquel; Godino, Javier; Garcia-Prats, Maria Dolores; Polo, Eduardo; Tres, Alejandro; Mouy, Magali; Saemundsdottir, Jona; Backman, Valgerdur M; Gudmundsson, Larus; Kristjansson, Kristleifur; Bergthorsson, Jon T; Kostic, Jelena; Frigge, Michael L; Geller, Frank; Gudbjartsson, Daniel; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Jonsson, Thorvaldur; von Holst, Susanna; Werelius, Barbro; Margolin, Sara; Lindblom, Annika; Mayordomo, Jose I; Haiman, Christopher A; Kiemeney, Lambertus A; Johannsson, Oskar Th; Gulcher, Jeffrey R; Thorsteinsdottir, Unnur; Kong, Augustine
Nature genetics, 07/2007, Letnik: 39, Številka: 7Journal Article
Familial clustering studies indicate that breast cancer risk has a substantial genetic component. To identify new breast cancer risk variants, we genotyped approximately 300,000 SNPs in 1,600 Icelandic individuals with breast cancer and 11,563 controls using the Illumina Hap300 platform. We then tested selected SNPs in five replication sample sets. Overall, we studied 4,554 affected individuals and 17,577 controls. Two SNPs consistently associated with breast cancer: ∼25% of individuals of European descent are homozygous for allele A of rs13387042 on chromosome 2q35 and have an estimated 1.44-fold greater risk than noncarriers, and for allele T of rs3803662 on 16q12, about 7% are homozygous and have a 1.64-fold greater risk. Risk from both alleles was confined to estrogen receptor-positive tumors. At present, no genes have been identified in the linkage disequilibrium block containing rs13387042. rs3803662 is near the 5′ end of TNRC9 , a high mobility group chromatin-associated protein whose expression is implicated in breast cancer metastasis to bone.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.